Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The daily Top 10 COVID papers

  Breast Cancer

  Free Subscription


11 Ann Surg Oncol
12 BMC Cancer
4 Breast Cancer
2 Breast Cancer (Auckl)
3 Breast Cancer (Dove Med Press)
7 Breast Cancer Res
13 Breast Cancer Res Treat
1 Cancer
1 Cancer Cell
1 Cancer Lett
7 Cancer Res
1 Carcinogenesis
1 Cell
2 Clin Breast Cancer
1 Clin Cancer Res
1 Eur J Cancer
3 Eur Radiol
1 Gene
1 Histopathology
1 Int J Cancer
1 Int J Oncol
4 J Biol Chem
1 J Clin Oncol
6 J Surg Oncol
2 Oncogene
1 Oncology (Williston Park)
1 PLoS One
1 Proc Natl Acad Sci U S A
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. WU ZY, Kim HJ, Lee J, Chung IY, et al
    Recurrence Outcomes After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction in Patients with Pure Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2020;27:1627-1635.
    PubMed         Abstract available

  2. BOEHM KM, Chen J, Trichter S, Abdallah H, et al
    Characterization of Recurrences Following Second Breast-Conserving Surgery with Intraoperative Radiotherapy.
    Ann Surg Oncol. 2020;27:1638-1644.
    PubMed         Abstract available

  3. WARNER E, Yee S, Seminsky M, Glass K, et al
    Effect of a Knowledge-Translation Intervention on Breast Surgeons' Oncofertility Attitudes and Practices.
    Ann Surg Oncol. 2020;27:1645-1652.
    PubMed         Abstract available

  4. MATEO AM, Mazor AM, Obeid E, Daly JM, et al
    Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes.
    Ann Surg Oncol. 2020;27:1679-1692.
    PubMed         Abstract available

  5. NERON M, Sajous C, Thezenas S, Piperno-Neumann S, et al
    Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.
    Ann Surg Oncol. 2020;27:1693-1699.
    PubMed         Abstract available

  6. BARRIO AV, Downs-Canner S, Edelweiss M, Van Zee KJ, et al
    Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
    Ann Surg Oncol. 2020;27:1617-1624.
    PubMed         Abstract available

  7. WU ZY, Kim HJ, Lee J, Chung IY, et al
    Oncologic Safety of Nipple-Sparing Mastectomy in Patients with Breast Cancer and Tumor-to-Nipple Distance
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09427.
    PubMed         Abstract available

  8. KANTOR O, Chang C, Yao K, Boughey J, et al
    Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers.
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09533.
    PubMed         Abstract available

  9. COCCO D, Valente SA
    Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic.
    Ann Surg Oncol. 2021 Jan 11. pii: 10.1245/s10434-020-09554.

  10. VALENTE SA, Tendulkar RD, Cherian S, Shah C, et al
    TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.
    Ann Surg Oncol. 2021 Jan 12. pii: 10.1245/s10434-020-09432.
    PubMed         Abstract available

  11. SHAH C, Keisch M, Khan A, Arthur D, et al
    Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 Jan 13. pii: 10.1245/s10434-020-09526.
    PubMed         Abstract available

    BMC Cancer

  12. TAKADA K, Kashiwagi S, Asano Y, Goto W, et al
    Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
    BMC Cancer. 2020;20:513.
    PubMed         Abstract available

  13. BOLDES T, Merenbakh-Lamin K, Journo S, Shachar E, et al
    R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
    BMC Cancer. 2020;20:531.
    PubMed         Abstract available

  14. FRENCH DP, Astley S, Brentnall AR, Cuzick J, et al
    What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
    BMC Cancer. 2020;20:570.
    PubMed         Abstract available

  15. EL ANSARI FZ, Jouali F, Marchoudi N, Bennani MM, et al
    Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
    BMC Cancer. 2020;20:747.
    PubMed         Abstract available

  16. FIROUZABADI D, Dehghanian A, Rezvani A, Mahmoudi L, et al
    Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
    BMC Cancer. 2021;21:47.
    PubMed         Abstract available

  17. BASET Z, Abdul-Ghafar J, Parpio YN, Haidary AM, et al
    Risk factors of breast cancer among patients in a tertiary care hospitals in Afghanistan: a case control study.
    BMC Cancer. 2021;21:71.
    PubMed         Abstract available

  18. OO KK, Kamolhan T, Soni A, Thongchot S, et al
    Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer.
    BMC Cancer. 2021;21:65.
    PubMed         Abstract available

  19. GENG SK, Fu SM, Ma SH, Fu YP, et al
    Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy.
    BMC Cancer. 2021;21:68.
    PubMed         Abstract available

  20. DEVECKA M, Duma MN, Wilkens JJ, Kampfer S, et al
    Craniospinal irradiation(CSI) in patients with leptomeningeal metastases: risk-benefit-profile and development of a prognostic score for decision making in the palliative setting.
    BMC Cancer. 2020;20:501.
    PubMed         Abstract available

  21. NILSSEN Y, Brustugun OT, Eriksen MT, Haug ES, et al
    Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.
    BMC Cancer. 2020;20:488.
    PubMed         Abstract available

  22. THERKILDSEN C, Rasmussen M, Smith-Hansen L, Kallemose T, et al
    Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
    BMC Cancer. 2020;20:345.
    PubMed         Abstract available

  23. TANABE Y, Shiraishi S, Hashimoto K, Ikeda K, et al
    Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients.
    BMC Cancer. 2020;20:325.
    PubMed         Abstract available

    Breast Cancer

  24. ADACHI Y, Okumura S, Sawaki M, Hattori M, et al
    Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
    Breast Cancer. 2020;27:716-723.
    PubMed         Abstract available

  25. CHANG YK, Chen CT, Wang M, Yang Y, et al
    Could ductoscopy alleviate the need of microdochectomy in pathological nipple discharge?
    Breast Cancer. 2020;27:607-612.
    PubMed         Abstract available

  26. ZAHA H, Motonari T, Abe N, Unesoko M, et al
    Fat necrosis in level I oncoplastic breast-conserving surgery focusing on a modified round block technique.
    Breast Cancer. 2020;27:567-572.
    PubMed         Abstract available

    Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review.
    Breast Cancer. 2021 Jan 11. pii: 10.1007/s12282-020-01213.
    PubMed         Abstract available

    Breast Cancer (Auckl)

  28. ODAN N, Kikawa Y, Matsumoto H, Minohata J, et al
    Real-World Outcomes of Treating Advanced Breast Cancer Patients With Palbociclib: A Multicenter Retrospective Cohort Study in Japan-The KBCOG-14 Study.
    Breast Cancer (Auckl). 2020;14:1178223420983843.
    PubMed         Abstract available

  29. ZHIDKOVA EM, Lylova ES, Savinkova AV, Mertsalov SA, et al
    A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420974667.
    PubMed         Abstract available

    Breast Cancer (Dove Med Press)

  30. PARAMBIL JV, Najim M, Mahmoud M, Abubeker IY, et al
    Breast Cancer Screening Practices in a Tertiary Care Center in the State of Qatar: A Cross-Sectional Survey.
    Breast Cancer (Dove Med Press). 2021;13:21-30.
    PubMed         Abstract available

  31. ASSEFA AA, Abera G, Geta M
    Breast Cancer Screening Practice and Associated Factors Among Women Aged 20-70 Years in Urban Settings of SNNPR, Ethiopia.
    Breast Cancer (Dove Med Press). 2021;13:9-19.
    PubMed         Abstract available

  32. PURWANTO I, Heriyanto DS, Widodo I, Hakimi M, et al
    MicroRNA-223 is Associated with Resistance Towards Platinum-based Chemotherapy and Worse Prognosis in Indonesian Triple-negative Breast Cancer Patients.
    Breast Cancer (Dove Med Press). 2021;13:1-7.
    PubMed         Abstract available

    Breast Cancer Res

  33. GABRIELSON M, Azam S, Hardell E, Holm M, et al
    Hormonal determinants of mammographic density and density change.
    Breast Cancer Res. 2020;22:95.
    PubMed         Abstract available

  34. TUAZON AMA, Lott P, Bohorquez M, Benavides J, et al
    Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.
    Breast Cancer Res. 2020;22:108.
    PubMed         Abstract available

  35. FUMAGALLI C, Ranghiero A, Gandini S, Corso F, et al
    Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
    Breast Cancer Res. 2020;22:107.
    PubMed         Abstract available

  36. MORSING M, Kim J, Villadsen R, Goldhammer N, et al
    Fibroblasts direct differentiation of human breast epithelial progenitors.
    Breast Cancer Res. 2020;22:102.
    PubMed         Abstract available

  37. NIEHOFF NM, Keil AP, Jones RR, Fan S, et al
    Outdoor air pollution and terminal duct lobular involution of the normal breast.
    Breast Cancer Res. 2020;22:100.
    PubMed         Abstract available

  38. LEE ARGOV EJ, Acheampong T, Terry MB, Rodriguez CB, et al
    Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.
    Breast Cancer Res. 2020;22:99.
    PubMed         Abstract available

  39. KUROZUMI S, Alsaleem M, Monteiro CJ, Bhardwaj K, et al
    Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets.
    Breast Cancer Res. 2020;22:85.
    PubMed         Abstract available

    Breast Cancer Res Treat

  40. HASSAN Z, Boulos F, Abbas J, El Charif MH, et al
    Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
    Breast Cancer Res Treat. 2020;182:317-323.
    PubMed         Abstract available

  41. STJEPANOVIC N, Lubinski J, Moller P, Randall Armel S, et al
    Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
    Breast Cancer Res Treat. 2021 Jan 10. pii: 10.1007/s10549-020-06072.
    PubMed         Abstract available

  42. QI P, Yang Y, Bai QM, Xue T, et al
    Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients.
    Breast Cancer Res Treat. 2021 Jan 13. pii: 10.1007/s10549-020-06075.
    PubMed         Abstract available

  43. ALEIXO GFP, Yu H, Chen YT, Nyrop KA, et al
    Myosteatosis evaluation using erector spinae and psoas muscles to predict adverse events during adjuvant chemotherapy for breast cancer.
    Breast Cancer Res Treat. 2021 Jan 10. pii: 10.1007/s10549-020-06061.
    PubMed         Abstract available

  44. ZHANG J, Liu Y, Pu S, He J, et al
    Spindle and kinetochoreassociated complex subunit 3 accelerates breast cancer cell proliferation and invasion through the regulation of Akt/Wnt/beta-catenin signaling.
    Breast Cancer Res Treat. 2021 Jan 9. pii: 10.1007/s10549-020-06078.
    PubMed         Abstract available

  45. WATANABE T, Honda T, Totsuka H, Yoshida M, et al
    Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults.
    Breast Cancer Res Treat. 2020;182:491-502.
    PubMed         Abstract available

  46. CRAGUN D, Weidner A, Tezak A, Clouse K, et al
    Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
    Breast Cancer Res Treat. 2020;182:421-428.
    PubMed         Abstract available

  47. IWAMOTO T, Hara F, Uemura Y, Mukai H, et al
    NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy.
    Breast Cancer Res Treat. 2020;182:325-332.
    PubMed         Abstract available

  48. MISRA S, Lee G, Maganti M, Koch CA, et al
    Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center.
    Breast Cancer Res Treat. 2020;182:367-379.
    PubMed         Abstract available

  49. RICHARDSON D, Zhan L, Mahtani R, McRoy L, et al
    A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application.
    Breast Cancer Res Treat. 2021 Jan 11. pii: 10.1007/s10549-020-06082.
    PubMed         Abstract available

  50. PALVE JS, Luukkaala TH, Kaariainen MT
    Predictive risk factors of complications in different breast reconstruction methods.
    Breast Cancer Res Treat. 2020;182:345-354.
    PubMed         Abstract available

  51. ANGARITA FA, Acuna SA, Cordeiro E, McCready DR, et al
    Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database.
    Breast Cancer Res Treat. 2020;182:429-438.
    PubMed         Abstract available

  52. LEE MK, Sanaiha Y, Kusske AM, Thompson CK, et al
    A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers.
    Breast Cancer Res Treat. 2020;182:299-303.
    PubMed         Abstract available


  53. HENLEY SJ, Thomas CC, Lewis DR, Ward EM, et al
    Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.
    Cancer. 2020;126:2250-2266.
    PubMed         Abstract available

    Cancer Cell

  54. XIAO Y, Cong M, Li J, He D, et al
    Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation.
    Cancer Cell. 2020 Dec 31. pii: S1535-6108(20)30660.
    PubMed         Abstract available

    Cancer Lett

  55. YANG Y, Li S, Li B, Li Y, et al
    FBXL10 promotes ERRalpha protein stability and proliferation of breast cancer cells by enhancing the mono-ubiquitylation of ERRalpha.
    Cancer Lett. 2021 Jan 12. pii: S0304-3835(21)00023.
    PubMed         Abstract available

    Cancer Res

  56. GHERGUROVICH JM, Esposito M, Chen Z, Wang JZ, et al
    Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
    Cancer Res. 2020;80:3820-3829.
    PubMed         Abstract available

  57. XING F, Zhao D, Wu SY, Tyagi A, et al
    Epigenetic and post-transcriptional modulation of SOS1 can promote breast cancer metastasis through obesity-activated c-Met signaling in African American women.
    Cancer Res. 2021 Jan 14. pii: 0008-5472.CAN-19-4031.
    PubMed         Abstract available

  58. TUBEUF H, Caputo SM, Sullivan T, Rondeaux J, et al
    Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.
    Cancer Res. 2020;80:3593-3605.
    PubMed         Abstract available

  59. WESTCOTT JM, Camacho S, Nasir A, Huysman ME, et al
    DeltaNp63-Regulated Epithelial-to-Mesenchymal Transition State Heterogeneity Confers a Leader-Follower Relationship That Drives Collective Invasion.
    Cancer Res. 2020;80:3933-3944.
    PubMed         Abstract available

  60. BRIDGES AE, Ramachandran S, Pathania R, Parwal U, et al
    RAD51AP1 deficiency reduces tumor growth by targeting stem cell self-renewal.
    Cancer Res. 2020 Jul 14. pii: 0008-5472.CAN-19-3713.
    PubMed         Abstract available

  61. PARK D, Bergin SM, Jones D, Ru P, et al
    Ablation of the Brca1-Palb2 Interaction Phenocopies Fanconi Anemia in Mice.
    Cancer Res. 2020;80:4172-4184.
    PubMed         Abstract available

    The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?
    Cancer Res. 2020;80:3799-3802.
    PubMed         Abstract available


  63. REN L, Guo D, Wan X, Qu R, et al
    EYA2 upregulates miR-93 to promote tumorigenesis of breast cancer by targeting and inhibiting the STING signaling pathway.
    Carcinogenesis. 2021 Jan 15. pii: 6101153. doi: 10.1093.
    PubMed         Abstract available


  64. BOWLING EA, Wang JH, Gong F, Wu W, et al
    Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
    Cell. 2021 Jan 13. pii: S0092-8674(20)31753-0. doi: 10.1016/j.cell.2020.
    PubMed         Abstract available

    Clin Breast Cancer

  65. SAGONA A, Gentile D, Anghelone CAP, Barbieri E, et al
    Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center.
    Clin Breast Cancer. 2020 Dec 17. pii: S1526-8209(20)30334.
    PubMed         Abstract available

  66. FERNANDES LE, Epstein CG, Bobe AM, Bell JSK, et al
    Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
    Clin Breast Cancer. 2020 Dec 18. pii: S1526-8209(20)30296.
    PubMed         Abstract available

    Clin Cancer Res

  67. FERNANDEZ-NOGUEIRA P, Mancino M, Fuster G, Lopez-Plana A, et al
    Tumor-Associated Fibroblasts Promote HER2-Targeted Therapy Resistance through FGFR2 Activation.
    Clin Cancer Res. 2020;26:1432-1448.
    PubMed         Abstract available

    Eur J Cancer

  68. FURLANETTO J, Mobus V, Schneeweiss A, Rhiem K, et al
    Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
    Eur J Cancer. 2021;145:44-52.
    PubMed         Abstract available

    Eur Radiol

  69. JANG HJ, Kim HJ, Chae YS, Lee SJ, et al
    Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement.
    Eur Radiol. 2020;30:4785-4794.
    PubMed         Abstract available

  70. AUTIER P, Burrion JB, Grivegnee AR
    AI for reading screening mammograms: the need for circumspection.
    Eur Radiol. 2020;30:4783-4784.
    PubMed         Abstract available

  71. KIM JJ, Kim JY
    Fusion of high b-value diffusion-weighted and unenhanced T1-weighted images to diagnose invasive breast cancer: factors associated with false-negative results.
    Eur Radiol. 2021 Jan 14. pii: 10.1007/s00330-020-07644.
    PubMed         Abstract available


  72. TANDON M, Othman AH, Winogradzki M, Pratap J, et al
    Bone metastatic breast cancer cells display downregulation of PKC-zeta with enhanced glutamine metabolism.
    Gene. 2021 Jan 11:145419. doi: 10.1016/j.gene.2021.145419.
    PubMed         Abstract available


  73. BADR NM, Spooner D, Steven J, Stevens A, et al
    Morphological and molecular changes following neoadjuvant endocrine therapy of ER positive breast cancer: implications for clinical practice.
    Histopathology. 2021 Jan 10. doi: 10.1111/his.14331.
    PubMed         Abstract available

    Int J Cancer

  74. PAN JW, Zabidi MMA, Chong BK, Meng MY, et al
    Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations, and immune activation.
    Int J Cancer. 2021 Jan 7. doi: 10.1002/ijc.33463.
    PubMed         Abstract available

    Int J Oncol

  75. LI W, Liu C, Zhao C, Zhai L, et al
    [Corrigendum] Downregulation of beta3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets1 network in triple-negative breast cancer.
    Int J Oncol. 2021 Jan 11. doi: 10.3892/ijo.2021.5169.
    PubMed         Abstract available

    J Biol Chem

  76. BORAH S, Bhowmick NA
    The adaptor protein SHCA launches cancer invasion.
    J Biol Chem. 2020;295:10560-10561.
    PubMed         Abstract available

  77. JARDIN I, Diez-Bello R, Falcon D, Alvarado S, et al
    Melatonin downregulates TRPC6, impairing store-operated calcium entry in triple negative breast cancer cells.
    J Biol Chem. 2021 Jan 8:100254. doi: 10.1074/jbc.RA120.015769.
    PubMed         Abstract available

  78. WU Q, Zhang C, Zhang K, Chen Q, et al
    ppGalNAc-T4-catalyzed O-Glycosylation of TGF-beta type receptor regulates breast cancer cells metastasis potential.
    J Biol Chem. 2020 Dec 3:100119. doi: 10.1074/jbc.RA120.016345.
    PubMed         Abstract available

  79. HORI N, Okada K, Takakura Y, Takano H, et al
    Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway.
    J Biol Chem. 2020;295:8798-8807.
    PubMed         Abstract available

    J Clin Oncol

  80. MAGNUSON A, Sedrak MS, Gross CP, Tew WP, et al
    Development and Validation of a Risk Tool for Predicting Severe Toxicity in Older Adults Receiving Chemotherapy for Early-Stage Breast Cancer.
    J Clin Oncol. 2021 Jan 14:JCO2002063. doi: 10.1200/JCO.20.02063.
    PubMed         Abstract available

    J Surg Oncol

  81. LEIPHRAKPAM PD, Chowdhury S, Wang J, Black JD, et al
    The role and therapeutic implications of PI3K signaling pathway in cancer.
    J Surg Oncol. 2021;123:39-41.

  82. HANSSON E, Edvinsson AC, Elander A, Kolby L, et al
    First-year complications after immediate breast reconstruction with a biological and a synthetic mesh in the same patient: A randomized controlled study.
    J Surg Oncol. 2021;123:80-88.
    PubMed         Abstract available

  83. EYRICH NW, Sloss KR, Howard RA, Klueh MP, et al
    Opioid prescribing exceeds consumption following common surgical oncology procedures.
    J Surg Oncol. 2021;123:352-356.
    PubMed         Abstract available

  84. SISCO M
    The burden of postmastectomy breast reconstruction.
    J Surg Oncol. 2020;122:1298-1299.

  85. ANDRADE WP, Goncalves GG, Medeiros LC, Araujo DCM, et al
    Low-cost, safe, and effective smoke evacuation device for surgical procedures in the COVID-19 age.
    J Surg Oncol. 2020;122:844-847.
    PubMed         Abstract available

  86. MASIA J
    The largest multicentre data collection on prepectoral breast reconstruction: The iBAG study.
    J Surg Oncol. 2020;122:848-860.
    PubMed         Abstract available


  87. CHAI TF, Manu KA, Casey PJ, Wang M, et al
    Isoprenylcysteine carboxylmethyltransferase is required for the impact of mutant KRAS on TAZ protein level and cancer cell self-renewal.
    Oncogene. 2020;39:5373-5389.
    PubMed         Abstract available

  88. BRUMMER G, Fang W, Smart C, Zinda B, et al
    CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments.
    Oncogene. 2020;39:2275-2289.
    PubMed         Abstract available

    Oncology (Williston Park)

  89. Continuing Advancements in Breast Cancer Care.
    Oncology (Williston Park). 2021;35:11-13.
    PubMed         Abstract available

    PLoS One

  90. GALILI B, Tekpli X, Kristensen VN, Yakhini Z, et al
    Efficient gene expression signature for a breast cancer immuno-subtype.
    PLoS One. 2021;16:e0245215.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  91. CHANG PH, Chen MC, Tsai YP, Tan GYT, et al
    Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  92. YI A, Jang MJ, Yim D, Kwon BR, et al
    Addition of Screening Breast US to Digital Mammography and Digital Breast Tomosynthesis for Breast Cancer Screening in Women at Average Risk.
    Radiology. 2021 Jan 12:203134. doi: 10.1148/radiol.2021203134.
    PubMed         Abstract available

  93. RAHBAR H
    Closing the Chapter on Supplemental Breast Cancer Screening with US.
    Radiology. 2021 Jan 12:204334. doi: 10.1148/radiol.2021204334.

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.